更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
RION与龙沙合作扩大基于外泌体的治疗药物生产规模 - 新闻医学网
RION engages Lonza to scale manufacturing exosome based therapeutics News-Medical
RION携手龙沙扩大基于外泌体的治疗药物生产规模 - 商业电讯
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics Business Wire
RION与龙沙合作开发可扩展外泌体药物生产技术 - 合同制药
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing Contract Pharma
龙沙同意扩大RION基于外泌体疗法的生产规模——GEN《基因工程与生物技术新闻》报道
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics GEN - Genetic Engineering and Biotechnology News
2025年十大合同开发与生产组织 - 基因工程与生物技术新闻
Top 10 Contract Development and Manufacturing Organizations 2025 GEN - Genetic Engineering and Biotechnology News
龙沙高管谈生产准备:应对细胞与基因疗法挑战——亚洲生物科技视野
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge BioSpectrum Asia
龙沙集团投资大规模生物制造、生物偶联及药品生产领域——DCAT价值链洞察
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing DCAT Value Chain Insights
Vaxcyte将Lonza位于Visp工厂的制造投资列为2024年关键支出——生物工艺国际报道
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure BioProcess International
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页